112 related articles for article (PubMed ID: 20035715)
21. Extrahepatic expression of NAD(P)H:menadione oxidoreductase, UDP glucuronosyltransferase-1A6, microsomal aldehyde dehydrogenase, and hepatic nuclear factor-1 alpha mRNAs in ch/ch and 14CoS/14CoS mice.
Vasiliou V; Reuter SF; Nebert DW
Biochem Biophys Res Commun; 1997 Apr; 233(3):631-6. PubMed ID: 9168903
[TBL] [Abstract][Full Text] [Related]
22. Combination of Double-Mediator System with Large-Scale Integration-Based Amperometric Devices for Detecting NAD(P)H:quinone Oxidoreductase 1 Activity of Cancer Cell Aggregates.
Ino K; Onodera T; Fukuda MT; Nashimoto Y; Shiku H
ACS Sens; 2019 Jun; 4(6):1619-1625. PubMed ID: 30995391
[TBL] [Abstract][Full Text] [Related]
23. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent.
Winski SL; Hargreaves RH; Butler J; Ross D
Clin Cancer Res; 1998 Dec; 4(12):3083-8. PubMed ID: 9865924
[TBL] [Abstract][Full Text] [Related]
24. The NAD(P)H:Quinone Oxidoreductase 1 induces cell cycle progression and proliferation of melanoma cells.
Garate M; Wani AA; Li G
Free Radic Biol Med; 2010 Jun; 48(12):1601-9. PubMed ID: 20226854
[TBL] [Abstract][Full Text] [Related]
25. NAD(P)H:quinone oxidoreductase 1 expression in multiple sclerosis lesions.
van Horssen J; Schreibelt G; Bö L; Montagne L; Drukarch B; van Muiswinkel FL; de Vries HE
Free Radic Biol Med; 2006 Jul; 41(2):311-7. PubMed ID: 16814112
[TBL] [Abstract][Full Text] [Related]
26. NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis.
Long DJ; Waikel RL; Wang XJ; Perlaky L; Roop DR; Jaiswal AK
Cancer Res; 2000 Nov; 60(21):5913-5. PubMed ID: 11085502
[TBL] [Abstract][Full Text] [Related]
27. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity.
Traver RD; Horikoshi T; Danenberg KD; Stadlbauer TH; Danenberg PV; Ross D; Gibson NW
Cancer Res; 1992 Feb; 52(4):797-802. PubMed ID: 1737339
[TBL] [Abstract][Full Text] [Related]
28. NAD(P)H: quinone oxidoreductase 1 and its potential protective role in cardiovascular diseases and related conditions.
Zhu H; Li Y
Cardiovasc Toxicol; 2012 Mar; 12(1):39-45. PubMed ID: 21818552
[TBL] [Abstract][Full Text] [Related]
29. Carboxylic acid drug-induced DNA nicking in HEK293 cells expressing human UDP-glucuronosyltransferases: role of acyl glucuronide metabolites and glycation pathways.
Southwood HT; DeGraaf YC; Mackenzie PI; Miners JO; Burcham PC; Sallustio BC
Chem Res Toxicol; 2007 Oct; 20(10):1520-7. PubMed ID: 17880178
[TBL] [Abstract][Full Text] [Related]
30. Problematic detoxification of estrogen quinones by NAD(P)H-dependent quinone oxidoreductase and glutathione-S-transferase.
Chandrasena RE; Edirisinghe PD; Bolton JL; Thatcher GR
Chem Res Toxicol; 2008 Jul; 21(7):1324-9. PubMed ID: 18588320
[TBL] [Abstract][Full Text] [Related]
31. Arsenite pretreatment enhances the cytotoxicity of mitomycin C in human cancer cell lines via increased NAD(P)H quinone oxidoreductase 1 expression.
Lin YL; Ho IC; Su PF; Lee TC
Toxicol Appl Pharmacol; 2006 Aug; 214(3):309-17. PubMed ID: 16494910
[TBL] [Abstract][Full Text] [Related]
32. The Menadione-Mediated WST1 Reduction by Cultured Astrocytes Depends on NQO1 Activity and Cytosolic Glucose Metabolism.
Ehrke E; Steinmeier J; Stapelfeldt K; Dringen R
Neurochem Res; 2021 Jan; 46(1):88-99. PubMed ID: 31902045
[TBL] [Abstract][Full Text] [Related]
33. Evidence for NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated quinone-dependent redox cycling via plasma membrane electron transport: A sensitive cellular assay for NQO1.
Tan AS; Berridge MV
Free Radic Biol Med; 2010 Feb; 48(3):421-9. PubMed ID: 19932748
[TBL] [Abstract][Full Text] [Related]
34. Phase II antioxidant enzyme activities in brain of male and female ACI rats treated chronically with estradiol.
Stakhiv TM; Mesia-Vela S; Kauffman FC
Brain Res; 2006 Aug; 1104(1):80-91. PubMed ID: 16822482
[TBL] [Abstract][Full Text] [Related]
35. Phase II-selective induction of hepatic drug-metabolizing enzymes by oltipraz -5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione-, 1,7-phenanthroline, and 2,2'-dipyridyl in rats is not accompanied by induction of intestinal enzymes.
Vargas M; Lamb JG; Franklin MR
Drug Metab Dispos; 1998 Feb; 26(2):91-7. PubMed ID: 9456293
[TBL] [Abstract][Full Text] [Related]
36. Biochemical and genetic analysis of NAD(P)H:quinone oxidoreductase 1 (NQO1).
Siegel D; Kepa JK; Ross D
Curr Protoc Toxicol; 2007; Chapter 4():Unit4.22. PubMed ID: 23045144
[TBL] [Abstract][Full Text] [Related]
37. Menadione-induced reactive oxygen species generation via redox cycling promotes apoptosis of murine pancreatic acinar cells.
Criddle DN; Gillies S; Baumgartner-Wilson HK; Jaffar M; Chinje EC; Passmore S; Chvanov M; Barrow S; Gerasimenko OV; Tepikin AV; Sutton R; Petersen OH
J Biol Chem; 2006 Dec; 281(52):40485-92. PubMed ID: 17088248
[TBL] [Abstract][Full Text] [Related]
38. NADPH-quinone oxidoreductase-1 mediates Benzo-[a]-pyrene-1,6-quinone-induced cytotoxicity and reactive oxygen species production in human EA.hy926 endothelial cells.
Shukla H; Gaje G; Koucheki A; Lee HY; Sun X; Trush MA; Zhu H; Li YR; Jia Z
Toxicol Appl Pharmacol; 2020 Oct; 404():115180. PubMed ID: 32739527
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxicity of RH1: NAD(P)H:quinone acceptor oxidoreductase (NQO1)-independent oxidative stress and apoptosis induction.
Tudor G; Alley M; Nelson CM; Huang R; Covell DG; Gutierrez P; Sausville EA
Anticancer Drugs; 2005 Apr; 16(4):381-91. PubMed ID: 15746574
[TBL] [Abstract][Full Text] [Related]
40. Higher activity of polymorphic NAD(P)H:quinone oxidoreductase in liver cytosols from blacks compared to whites.
Covarrubias VG; Lakhman SS; Forrest A; Relling MV; Blanco JG
Toxicol Lett; 2006 Jul; 164(3):249-58. PubMed ID: 16478651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
